MDMA Statement on 21st Century Cures Discussion Draft

WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today in response to the latest “21st Century Cures” discussion draft:

"The strong, bipartisan work that has resulted in the latest ‘21st Century Cures’ discussion draft is a testament to the passion of Chairman Upton and Congresswoman DeGette, and every Member of Congress who recognizes the unique role of medical technology innovation.

“MDMA looks forward to reviewing the latest draft which includes the input of countless stakeholders, and represents a comprehensive attempt to accelerate getting American innovation into the hands of America’s patients and providers.

“MDMA thanks Chairman Upton and Congresswoman DeGette for their leadership on this important work and we will continue to help them advance the common goals of improving patient care and innovation.”